within Pharmacolibrary.Drugs.ATC.N;

model N05AH03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.0004166666666666667,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006166666666666667,
    Tlag           = 15.0,            
    Vdp             = 0.094,
    k12             = 40,
    k21             = 40
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05AH03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Olanzapine is an atypical antipsychotic medication primarily used in the treatment of schizophrenia and bipolar disorder. It works mainly by antagonizing dopamine and serotonin receptors in the brain. Olanzapine is an approved drug and is currently in clinical use worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects (both sexes), after a single oral dose. Data derived from population pharmacokinetic analysis.</p><h4>References</h4><ol><li><p>Correll, CU, et al., &amp; Saklad, SR (2021). Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. <i>CNS drugs</i> 35(1) 39–59. DOI:<a href=\"https://doi.org/10.1007/s40263-020-00779-5\">10.1007/s40263-020-00779-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33507525/\">https://pubmed.ncbi.nlm.nih.gov/33507525</a></p></li><li><p>Spanarello, S, &amp; La Ferla, T (2014). The pharmacokinetics of long-acting antipsychotic medications. <i>Current clinical pharmacology</i> 9(3) 310–317. DOI:<a href=\"https://doi.org/10.2174/15748847113089990051\">10.2174/15748847113089990051</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23343447/\">https://pubmed.ncbi.nlm.nih.gov/23343447</a></p></li><li><p>Sutar, R, et al., &amp; Chaudhary, P (2021). Antipsychotics and hemodialysis: A systematic review. <i>Asian journal of psychiatry</i> 55 102484–None. DOI:<a href=\"https://doi.org/10.1016/j.ajp.2020.102484\">10.1016/j.ajp.2020.102484</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33341539/\">https://pubmed.ncbi.nlm.nih.gov/33341539</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05AH03;
